New pill for enlarged prostate symptoms compared to standard care
Part of Kidney & urinary clinical trials.
This study compares a new once-daily pill to an existing medication for men with an enlarged prostate. It aims to see if the new pill is better at improving urinary symptoms and urine flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male between the ages of 50 and 75.
- You need a diagnosis of an enlarged prostate (benign prostatic hyperplasia) with bothersome urinary symptoms.
- Your prostate size must be at least 20 milliliters as measured by an ultrasound.
- Your PSA (a blood test for prostate health) must be 4 or lower.
- You must not have had prostate surgery or other invasive prostate treatments before.
- You must agree to use effective birth control for up to 6 months after the last dose (even if you are not planning to have children).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining two medicines works better than one alone for easing urinary symptoms caused by an enlarged prostate. If you have bothersome symptoms and a larger prostate, this study may help you find a more effective treatment.
This study compares two medicines (silodosin and tamsulosin) that help with urine flow in men with an enlarged prostate. You would take one medicine for a period, then the other, to see which works better for you.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.
This study is for men with moderate to severe BPH symptoms who haven't responded well to one medicine alone. It tests a combination of two drugs (solifenacin and tamsulosin) to see if they improve symptom control and quality of life.
This study tests a combination of two medicines in a single pill to see if they work better together to reduce frequent urination and sudden urges in men with an enlarged prostate. The goal is to improve quality of life by easing these bothersome symptoms.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.